Related Experiment Videos

Is the genetic code really a frozen accident? New evidence from in vitro selection

R D Knight¹, L F Landweber

¹Department of Ecology and Evolutionary Biology, Princeton University, New Jersey 08544, USA.

Annals of the New York Academy of Sciences

|July 23, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS.

Leukemia·2013

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.

Leukemia·2009

Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond--9th European Hematology Association Congress Geneva, Switzerland, 10-13 June 2004.

Transfusion medicine (Oxford, England)·2007

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies.

European journal of cancer (Oxford, England : 1990)·2006

Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004

Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.

Journal of molecular and cellular cardiology·2003

See all related articles